Researchers applied the next generation phage display mimotope variation analysis to profile antibody response and dissected the role of humoral immunity in targeted cancer therapies, namely anti-tumor dendritic cell vaccine and immunotherapy with anti-PD-1 monoclonal antibodies.
[Communications Medicine]